Intravacc launches phase 1 trial for intranasal COVID-19 booster vaccine
Intravacc has enrolled the first participant in a phase I first in-human clinical trial of Avacc 10, the company’s SARS-CoV-2 intranasal subunit vaccine, as a booster shot.
Archives for December 6, 2022
Antibody drug discovery biotech raises $12m in seed funding
Infinimmune, a biotech pioneering new methods for antibody drug discovery and development, has closed a $12 million seed round: helping it develop its R&D capabilities.
GSK, Sanofi, and Takeda align with research communities to advance Singapore's biologics manufacturing capabilities
Global pharma giants, GSK, Sanofi, and Takeda, are set to collaborate with Singapore-based researchers to boost innovation in local biologics and vaccines manufacturing.
Licensing deal aimed at progressing cell and gene therapies in the treatment of rare diseases
Curamys, a South Korean biotech developing cell and gene therapy using cell fusion technology to treat rare intractable diseases, has signed a strategic platform licensing agreement with US tech developer, MaxCyte.